These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24163009)

  • 81. Update of genetic susceptibility in patients with Kawasaki disease.
    Yoon KL
    Korean J Pediatr; 2015 Mar; 58(3):84-8. PubMed ID: 25861330
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Genetic polymorphism of SMAD5 is associated with Kawasaki disease.
    Cho JH; Han MY; Cha SH; Jung JH; Yoon KL
    Pediatr Cardiol; 2014 Apr; 35(4):601-7. PubMed ID: 24163009
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Genetic variants of ADAM17 are implicated in the pathological process of Kawasaki disease and secondary coronary artery lesions via the TGF-β/SMAD3 signaling pathway.
    Peng Q; Deng Y; Yang X; Leng X; Yang Y; Liu H
    Eur J Pediatr; 2016 May; 175(5):705-13. PubMed ID: 26833052
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Promoter polymorphism (rs3755724, -55C/T) of tissue inhibitor of metalloproteinase 4 (TIMP4) as a risk factor for Kawasaki disease with coronary artery lesions in a Korean population.
    Ban JY; Yoon KL; Kim SK; Kang S; Chung JH
    Pediatr Cardiol; 2009 Apr; 30(3):331-5. PubMed ID: 19048177
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Genetic analysis of MMP gene polymorphisms in patients with Kawasaki disease.
    Ikeda K; Ihara K; Yamaguchi K; Muneuchi J; Ohno T; Mizuno Y; Hara T
    Pediatr Res; 2008 Feb; 63(2):182-5. PubMed ID: 18091353
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Single-nucleotide Polymorphism rs17860041 A/C in the Promoter of the
    Shi R; Luo Y; Li S; Kong M; Liu X; Yu M; Wu J; Huang L; Yang Z
    Immunol Invest; 2021 Feb; 50(2-3):230-242. PubMed ID: 32079425
    [No Abstract]   [Full Text] [Related]  

  • 87. Genetics of Kawasaki disease: what we know and don't know.
    Onouchi Y
    Circ J; 2012; 76(7):1581-6. PubMed ID: 22789975
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey.
    Nakamura Y; Yashiro M; Uehara R; Sadakane A; Tsuboi S; Aoyama Y; Kotani K; Tsogzolbaatar EO; Yanagawa H
    J Epidemiol; 2012; 22(3):216-21. PubMed ID: 22447211
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Lack of an association between E-selectin gene polymorphisms and risk of Kawasaki disease.
    Shirakawa T; Ikeda K; Nishimura S; Kuniba H; Nakashima K; Motomura H; Mizuno Y; Zaitsu M; Nakazato M; Maeda T; Hamasaki Y; Hara T; Moriuchi H
    Pediatr Int; 2012 Aug; 54(4):455-60. PubMed ID: 22414298
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Pachyman treatment improves CD4+CD25+ Treg counts and serum interleukin 4 and interferon γ levels in a mouse model of Kawasaki disease.
    Chu MP; Wang D; Zhang YY; Li BQ; Zhou AH; Chen XW; Qian Y
    Mol Med Rep; 2012 May; 5(5):1237-40. PubMed ID: 22367425
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Transforming growth factor beta receptor II polymorphisms are associated with Kawasaki disease.
    Choi YM; Shim KS; Yoon KL; Han MY; Cha SH; Kim SK; Jung JH
    Korean J Pediatr; 2012 Jan; 55(1):18-23. PubMed ID: 22359526
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Polymorphisms of transforming growth factor-β signaling pathway and Kawasaki disease in the Taiwanese population.
    Kuo HC; Onouchi Y; Hsu YW; Chen WC; Huang JD; Huang YH; Yang YL; Chao MC; Yu HR; Juan YS; Kuo CM; Yang KD; Huang JS; Chang WC
    J Hum Genet; 2011 Dec; 56(12):840-5. PubMed ID: 22011813
    [TBL] [Abstract][Full Text] [Related]  

  • 93. SMAD4 mutation segregating in a family with juvenile polyposis, aortopathy, and mitral valve dysfunction.
    Andrabi S; Bekheirnia MR; Robbins-Furman P; Lewis RA; Prior TW; Potocki L
    Am J Med Genet A; 2011 May; 155A(5):1165-9. PubMed ID: 21465659
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis.
    van de Laar IM; Oldenburg RA; Pals G; Roos-Hesselink JW; de Graaf BM; Verhagen JM; Hoedemaekers YM; Willemsen R; Severijnen LA; Venselaar H; Vriend G; Pattynama PM; Collée M; Majoor-Krakauer D; Poldermans D; Frohn-Mulder IM; Micha D; Timmermans J; Hilhorst-Hofstee Y; Bierma-Zeinstra SM; Willems PJ; Kros JM; Oei EH; Oostra BA; Wessels MW; Bertoli-Avella AM
    Nat Genet; 2011 Feb; 43(2):121-6. PubMed ID: 21217753
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Transforming growth factor-beta signaling pathway in patients with Kawasaki disease.
    Shimizu C; Jain S; Davila S; Hibberd ML; Lin KO; Molkara D; Frazer JR; Sun S; Baker AL; Newburger JW; Rowley AH; Shulman ST; Burgner D; Breunis WB; Kuijpers TW; Wright VJ; Levin M; Eleftherohorinou H; Coin L; Popper SJ; Relman DA; Fury W; Lin C; Mellis S; Tremoulet AH; Burns JC
    Circ Cardiovasc Genet; 2011 Feb; 4(1):16-25. PubMed ID: 21127203
    [TBL] [Abstract][Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.